Your session is about to expire
← Back to Search
Topical Agent
TCA for Actinic Cheilitis
Phase 4
Waitlist Available
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Inclusion criteria will include all patients with actinic cheilitis that do not meet
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial
Summary
This trial investigates the use of TCA, a chemical solution that peels off damaged skin, in treating patients with actinic cheilitis, a sun-damaged condition of the lower lip. The goal is to see if TCA can effectively treat this condition and prevent it from turning into cancer. Trichloroacetic acid (TCA) has a long history of use for light and medium-depth peels, including the treatment of actinic keratoses.
Eligible Conditions
- Actinic Cheilitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adverse Events
Recurrence Rate
Remission rate
+1 moreSecondary study objectives
Healing Time
patient satisfaction
Awards & Highlights
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TCA pealExperimental Treatment1 Intervention
Patients will have their actinic cheilitis treated with a TCA peal.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
287 Previous Clinical Trials
94,322 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger